Factors associated with parent-reported suicide threats by children and adolescents with community-diagnosed bipolar disorder.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 15935246)

Published in J Affect Disord on June 01, 2005

Authors

Demitri Papolos1, John Hennen, Melissa S Cockerham

Author Affiliations

1: The Juvenile Bipolar Research Foundation, 550 Ridgewood Road, Maplewood, NJ 07040, USA.

Articles by these authors

Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry (2004) 3.76

The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up. J Pers Disord (2005) 3.74

Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry (2004) 3.26

The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. Am J Psychiatry (2003) 3.25

The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry (2003) 3.00

Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord (2006) 2.74

Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes (2006) 2.42

Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry (2010) 2.39

A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord (2003) 2.03

EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry (2002) 1.98

Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause (2002) 1.92

Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. J Clin Psychiatry (2004) 1.90

Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years. J Pers Disord (2005) 1.85

Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord (2003) 1.74

Prediction of the 10-year course of borderline personality disorder. Am J Psychiatry (2006) 1.60

Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv (2007) 1.48

Birth outcomes following prenatal exposure to antidepressants. J Clin Psychiatry (2007) 1.28

Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv (2003) 1.19

Reported childhood onset of self-mutilation among borderline patients. J Pers Disord (2006) 1.18

Severity of reported childhood sexual abuse and its relationship to severity of borderline psychopathology and psychosocial impairment among borderline inpatients. J Nerv Ment Dis (2002) 1.17

Smaller frontal lobe white matter volumes in depressed adolescents. Biol Psychiatry (2002) 1.11

Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. Am J Psychiatry (2004) 1.10

Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res (2004) 1.10

Adult experiences of abuse reported by borderline patients and Axis II comparison subjects over six years of prospective follow-up. J Nerv Ment Dis (2005) 1.08

Genetics of suicide: an overview. Harv Rev Psychiatry (2004) 1.07

Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biol Psychiatry (2002) 1.06

Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate. Psychiatry Res (2003) 1.04

Shape differences in the corpus callosum in first-episode schizophrenia and first-episode psychotic affective disorder. Am J Psychiatry (2002) 1.04

Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry (2005) 1.04

A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study. Neuropsychopharmacology (2005) 1.02

An ongoing study of group treatment for men involved in problematic Internet-enabled sexual behavior. Cyberpsychol Behav (2006) 1.00

Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probands. J Pers Disord (2004) 1.00

Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord (2003) 0.98

A DSM-IV Axis I comorbidity study of males (n = 120) with paraphilias and paraphilia-related disorders. Sex Abuse (2002) 0.97

Manual assisted cognitive treatment for deliberate self-harm in borderline personality disorder patients. J Pers Disord (2006) 0.95

Sexual relationship difficulties among borderline patients and axis II comparison subjects. J Nerv Ment Dis (2003) 0.95

Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J Clin Psychiatry (2007) 0.94

Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry (2003) 0.93

Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord (2008) 0.92

Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Hum Psychopharmacol (2005) 0.92

Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. J Affect Disord (2007) 0.91

Is lithium still worth using? An update of selected recent research. Harv Rev Psychiatry (2002) 0.89

A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry (2004) 0.88

Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment. Psychopharmacology (Berl) (2005) 0.88

A strategy for identifying phenotypic subtypes: concordance of symptom dimensions between sibling pairs who met screening criteria for a genetic linkage study of childhood-onset bipolar disorder using the Child Bipolar Questionnaire. J Affect Disord (2006) 0.85

Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. J Clin Psychiatry (2004) 0.84

Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both. Hum Psychopharmacol (2006) 0.83

Brain proton magnetic resonance spectroscopy in Alzheimer disease: changes after treatment with xanomeline. Am J Geriatr Psychiatry (2002) 0.83

Olanzapine versus placebo in acute mania: treatment responses in subgroups. J Clin Psychopharmacol (2003) 0.83

Risk of mania with antidepressants. Arch Pediatr Adolesc Med (2005) 0.83

The child bipolar questionnaire: a dimensional approach to screening for pediatric bipolar disorder. J Affect Disord (2006) 0.82

Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3). J Psychiatr Res (2007) 0.81

Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia. Am J Psychiatry (2005) 0.81

Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry (2005) 0.81

Recovery and functional outcomes following olanzapine treatment for bipolar I mania. Bipolar Disord (2005) 0.81

Hypersexual desire in males: are males with paraphilias different from males with paraphilia-related disorders? Sex Abuse (2003) 0.81

Greater depression severity in elderly patients with memory complaints is associated with decreased left temporal-parietal dominance indicated by dynamic susceptibility contrast magnetic resonance imaging cerebral blood volume measures. Am J Geriatr Psychiatry (2007) 0.79

A comparison of the Aberrant Behavior Checklist and the GAF among adults with mental retardation and mental illness. Psychiatr Serv (2005) 0.78

Cerebral blood volume and clinical changes on the third day of placebo substitution for SSRI treatment. Biol Psychiatry (2003) 0.78

Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry (2003) 0.77

Estrogen therapy and noncognitive psychiatric signs and symptoms in elderly patients with dementia. Am J Psychiatry (2002) 0.76

Obsessive fears about harm to self or others and overt aggressive behaviors in youth diagnosed with juvenile-onset bipolar disorder. J Affect Disord (2005) 0.76

Assessing the utility of atypical antipsychotic medication in adults with mild mental retardation and comorbid psychiatric disorders. J Clin Psychiatry (2005) 0.75

Mild traumatic brain injury in psychiatric inpatients. J Neurosci Nurs (2005) 0.75